Navigation Links
Transplant Head Honcho forced to dismount

The Abdominal Transplant Program, beset with administrative problems, experienced another upheaval. In a recent statement, The UCSD communicated its decision to relieve // Dr. Hart, the Director of the program for liver and kidney transplants, of his administrative responsibilities. Notwithstanding, Dr Hart will still continue as a full-time surgeon and member of the University's transplant team.

The UC San Diego, disappointed with the manner in which Dr Marquis Hart had conducted the UC Irvine’s Liver program, perceived to have misled organ officials, instigated his exit. Dr Marquis Hart had been offering part time services to the UCI since 2002 till the fall of 2005. During his tenure, The UCI liver program suffered huge setbacks prompting its closure.

Federal officials said that though the UCI was given 122 livers between 2004 and 2005, only 12 transplantations had occurred, a record low for any such program in the state. The UCI also did not have its own team of surgeons and therefore had to avail the services of Marquis and another UCSD surgeon. Further, Medicare also decided to cancel the payment for UCI’s Liver transplants.

Dr Hart was also part of a contract that allowed him to be a consultant surgeon for the UCI. The financial contract, according to Dr Thomas MacAfee, was between the UC Irvine and The UCSD Department of Surgery, and confirmed that the UCSD was not in the eye of any mischief or allegations. In the UCSD statement, the Chief Executive Officer, Richard Liekweg has reiterated that this is not a slur on the Doctor’s skill and commitment to his work. Infact, Dr Hart is regarded as an outstanding surgeon, deeply committed to his patients.

'"/>




Page: 1

Related medicine news :

1. Stem Cell Transplants May Be Effective For MS Patients
2. Drugs Deter Heart Disease for Transplant Patients
3. Better Drug for Heart Transplant
4. Kidney Failure after Non-Kidney Transplants
5. Measles Risk in Transplant Patients
6. Transplants Help Liver Cancer Patients
7. Steroid-Free Liver Transplants
8. Pancreas Transplant for Diabetics
9. Reducing The Risk Of Fractures After a Heart Transplant
10. A Urine Test Could Predict Rejection In Transplant Patients
11. Thawed Ovarian Transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier ... professionals caring for those suffering from the full spectrum of disordered eating, announced today ... disorders professionals from nearly all 50 states and several countries converged on the Green ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the ... product – with nearly 2,000 consumers (and counting) already backing the campaign. ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward ... Learning How to Walk with God #TruthwithGrace” is the creation of published author ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The IPF pipeline is very strong with a total of ... Co., Inc., Biogen and Sanofi are involved in the development of the ... one is in Phase III stage, 15 are in Phase II stage, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: